The United European Gastroenterology has launched a report on "Nutrition and Chronic Digestive Diseases: An Action Plan for Europe" to which EFCCA amongst other organisations has contributed. Follow this link to access the report: Read Report
New survey on the indirect costs of IBD. The aim of the study is to assess the influence of IBD on the patients productivity at work and relevant costs for society. www.ibdcosts.eu Within the framework of World IBD Day 2019 the European Federation of Crohn’s and Ulcerative Colitis Associations (EFCCA) is supporting a new study which aims to assess the indirect or invisible costs of Crohn’s disease and ulcerative colitis, collectively known as Inflammatory Bowel Disease (IBD).
FOR IMMEDIATE RELEASE
Making the Invisible Visible - a Europe wide study to reveal the invisible costs of IBD to society
There are some topics that are hard to discuss, for which people may not want to share their opinions. Surgery in people with Inflammatory Bowel Disease (IBD) is one of these neglected topics. It is, howwever, extremely relevant and important to collect information about the perception of surgery, the impact on the quality of life, and worries baout it.
We are looking for people with IBD who can provide us their views about surgery, by completeing a survey that lasts about 15 minutes.
EUnetHTA deems patient involvement very important in the production of Joint Assessment reports. We recognise that patients and those who support them have unique knowledge about what it is like to live with a specific disease or medical condition. We believe patient groups can help us understand patients’ unique perspectives by collecting and presenting patients’ and carers/care-givers’ views and experiences by engaging with a wide range of patients.
Our next General Assembly will take place in Prague from 24-26 May 2019 in association with our colleagues from Pacienti IBD (Czech Republic).
Looking forward to seeing you there! #efccaga2019
We are proud to announce that the third video animation of our My IBD Journey series is now available. The video entitled “Mission: Remission” explains the different types of remission and provides advice on how you can work towards achieving remission, and the importance of staying on track with your treatment.
The pharmaceutical company, Pfizer, has launched a call for proposal within the framework of the "Independent Grants for Learning & Change".
The call is for proposals on "Appropriate Immunisations in Adult Patients with Immune-Mediated Inflammatory Conditions".
Follow the link for more informatio: https://www.pfizer.com/sites/default/files/rfp_files/IGLC_RFP_2018RA2_Im...